Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Latest news

12/26/2018 RNC Pharma Database Update: Pharmaceutical Drug Production in Russia (November 2018)

Between January and November 2018, Russia produced 305.1 bln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is in monetary terms 1.1% higher than that of the same period of 2017. In physical terms, the dynamics are -5.6%, with 3.85 bln units.

12/24/2018 Database Update: Import of Veterinary Drugs, Feed, Feed Supplements and APIs to Russia (October 2018)

Between January and October 2018, Russia imported 52.9 bln RUB worth of veterinary products (free circulation prices), which is in monetary terms 14 higher than that of the same period of 2017. Feed supplements have the biggest import volume, with 30.4 bln RUB and +15%. They are followed by veterinary drugs, with 20.9 bln RUB and +12.8%. Veterinary APIs are the last, with 1.6 bln RUB and + 11.7%.

12/23/2018 Database Update: Pharmaceutical Drug Export from Russia (August 2018)

Between January and August 2017, Russia exported 13.8 bln RUB worth of pharmaceutical drugs (excluding exports to the EEU countries), which is in monetary terms 7.5% higher than that of the same period of 2017. The dynamics in physical terms are -6%, with 0.32 bln units of pharmaceuticals. If calculated in minimum dosage units (MDU), the dynamics are also negative, -11.5%.

12/21/2018 Database Update: API Import to Russia (October 2018)

Between January and October 2018, Russia imported 78.5 bln RUB worth of APIs (free circulation prices, VAT included), which is in monetary terms 29% higher than that of the same period of 2017. The current dynamics can only be explained by higher prices, because the dynamics in physical terms are -7.3% (9.4 tons of APIs.)

12/19/2018 Database Update: Pharmaceutical Drug Import to Russia (October 2018)

Between January and October 2018, Russia imported 427.1 bln RUB worth of ready-made pharmaceutical drugs (free circulation prices), which is in monetary terms 1.5% higher than that of the same period of 2017, and 87.9 bln RUB worth of in-bulk pharmaceuticals, which is in monetary terms 12.5% higher than that of the same period of 2017. In total, the dynamics in monetary terms are +3.2%.

All news [127]

Our competences

RNC Pharma is focused on providing information about development trends of Russian pharmaceutical market infrastructure component. Our experts also provide services on strategic marketing, such as forecasting, business planning, etc.